Filing Flows › Companies › Teladoc Health › Report card
Teladoc Health earnings report card
Every report on file against what analysts and the company itself expected, and what the stock did
Beat rate5 of 5 reports beat the EPS estimate
Teladoc Health (TDOC) beat the analysts' EPS estimate in 5 of its last 5 reports (100%), by +33.0% on average. On report days the stock moved 17.8% in either direction on median (largest 35.3%), rising 80% of the time; after a beat it rose 80% of the time.
Report by report
| Quarter | Reported | EPS est. | EPS reported | Surprise | Revenue guided | Revenue reported | Stock, the day | vs market |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | Oct 28, 2026 | −$0.19 | −$0.12 | +36.5% | $569M–$609M | $605M (within) | +35.3% | +35.4% |
| Q2 2026 | Jul 29, 2026 | −$0.23 | −$0.20 | +10.8% | $597M–$626M | $607M (within) | -29.7% | -29.8% |
| Q1 2026 | Apr 29, 2026 | −$0.39 | −$0.28 | +26.7% | — | $614M | +1.0% | +0.0% |
| Q4 2025 | Feb 25, 2026 | −$0.22 | −$0.10 | +52.1% | — | $642M | +17.8% | +17.6% |
| Q3 2025 | Oct 29, 2025 | −$0.31 | −$0.19 | +38.9% | — | $626M | +4.5% | +5.6% |
Estimates and reported EPS are the Street's adjusted figures. Revenue guided is the last range the company gave before the report. Revenue reported is from the company's filing. The stock's move is close to close around the report date (the close before it to the close of the session after), against SPY for the market column.
Charts
The earnings-day move
Over 5 reports the stock moved 17.8% on median on the day (close to close), the largest move 35.3%.
After a beat the stock rose 80% of the time (5 beats).
The next report: what to expect → Teladoc Health: every quarter →
Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.